BeStock  
Stocks › Biotechnology › PVLA

Palvella Therapeutics PVLA

US equityMarket cap rank #2653Biotechnology
$142.85 −$2.92 (-2.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $142.85 0.00%
Open$143.10
Prev close$145.77
Day range$142.22 – $148.69
Volume192.7K
Market cap$2.09B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership108.9%-0.40 pts vs. prior quarter
Institutions holding244+1 vs. prior quarter
Insider trades (recent)29 buys / 20 sellsNet buying
Short interest18.06% of floatDays to cover 11.5 · as of 30 Oct 2026
Short-sale volume share17.7%5-day average of daily volume

Short-sale volume as % of daily volume

12%17%23%29%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$7.26M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

+$3.4MSuper+$3.8MBig+$3.5MMid+$800.1KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 33.8% of shares outstanding.

Largest holders

  • Montanova Capital, LLC7.77%
  • Jennison Associates LLC7.54%
  • BlackRock6.77%
  • Frazier Life Sciences Management, LP6.04%
  • Wesley Kaupinen5.65%
  • First Light Asset Management, LLC5.28%
  • BVF Partners L.P.4.60%
  • T. Rowe Price Group, Inc.4.37%

By investor type

  • Mutual Fund64.34%
  • Hedge Fund19.60%
  • VC/PE Fund14.72%
  • Individual/Insider7.70%
  • Private Company4.18%
  • Public Company3.23%
  • Sovereign Wealth Fund1.81%
  • Insurance Company0.38%

Reported short interest has risen from 14.92% to 18.06% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Westfield Capital Management Company, L.P. Mutual Fund 2026/Q3 +396,045 2.7%
Invesco Ltd. Mutual Fund 2026/Q3 +232,082 1.8%
William Blair Investment Management, LLC Mutual Fund 2026/Q3 +195,070 1.3%
Jennison Associates LLC Mutual Fund 2026/Q3 +141,033 7.5%
BlackRock Mutual Fund 2026/Q3 +71,334 6.8%
Nan Fung Trinity (HK) Limited VC/PE Fund 2026/Q3 +52,630 0.4%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +46,995 0.3%
UBS Asset Management Mutual Fund 2026/Q3 +45,933 1.3%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +35,432 2.1%
William Blair Investment Management, LLC Mutual Fund 2026/Q3 +68,710 0.5%
Jennison Associates LLC Mutual Fund 2026/Q3 +320,008 6.7%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +236,304 4.4%
BlackRock Mutual Fund 2026/Q3 +231,504 6.4%
State Street Global Advisors Mutual Fund 2026/Q3 +194,173 4.5%
OrbiMed Advisors LLC VC/PE Fund 2026/Q3 +157,760 2.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
10 Nov 2026 Jeffrey Martini Chief Scientific Officer Derivative Exercise and Sale -12,500 $172.12 –
9 Nov 2026 Jeffrey Martini Chief Scientific Officer Intent to Sell (Form 144) -50,000 $174.08 –
20 Oct 2026 Kathleen Goin Chief Operating Officer Derivative Exercise and Sale -4,313 $126.19 –
13 Oct 2026 George Jenkins Independent Chairperson Automatic Disposition -27,500 $136.44 132,616
12 Oct 2026 George Jenkins Independent Chairperson Intent to Sell (Form 144) -27,500 $134.38 –
15 Sep 2026 Kathleen Goin Chief Operating Officer Derivative Exercise and Sale -4,302 $153.24 –
14 Sep 2026 George Jenkins Independent Chairperson Automatic Disposition -27,500 $153.10 160,116
10 Sep 2026 George Jenkins Independent Chairperson Intent to Sell (Form 144) -27,500 $150.39 –
1 Sep 2026 Christopher Kiritsy Independent Director Derivative Exercise and Sale -313 $157.00 250
18 Aug 2026 Kathleen Goin Chief Operating Officer Derivative Exercise and Sale -4,302 $156.77 –
14 Jul 2026 Kathleen Goin Chief Operating Officer Derivative Exercise and Sale -4,302 $150.25 –
28 Jun 2026 Matthew Pauls Director Other Derivative Acquisition +6,000 $154.84 6,000
16 Jun 2026 Kathleen Goin Chief Operating Officer Derivative Exercise and Sale -4,302 $112.23 –
11 Jun 2026 Matthew Korenberg CFO, Corporate Secretary & Treasurer Derivative Exercise and Retained +1,000 $13.60 1,000
9 Jun 2026 George Jenkins Independent Chairperson Other Derivative Acquisition +3,000 $102.19 3,000
9 Jun 2026 Elaine Heron Independent Director Other Derivative Acquisition +3,000 $102.19 3,000
9 Jun 2026 Todd Davis Independent Director Other Derivative Acquisition +3,000 $102.19 3,000
9 Jun 2026 Christopher Kiritsy Independent Director Other Derivative Acquisition +3,000 $102.19 3,000
9 Jun 2026 Tadd Wessel Independent Director Other Derivative Acquisition +3,000 $102.19 3,000
9 Jun 2026 John Doux Independent Director Other Derivative Acquisition +3,000 $102.19 3,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 2,601,661 18.1% 11.5
15 Oct 2026 2,407,482 16.7% 9.8
30 Sep 2026 2,524,140 17.5% 10.7
15 Sep 2026 2,325,699 16.1% 12.8
31 Aug 2026 2,291,288 15.9% 11.1
14 Aug 2026 2,149,544 14.9% 12.8

Discussion

No comments yet — be the first to weigh in on PVLA.

Sign in to join the discussion.

Scroll to Top